Side-by-side comparison of AI visibility scores, market position, and capabilities
Frankfurt-listed (ETR: ALV) global insurer and asset manager serving 100M+ customers with PIMCO's $1.8T+ fixed income AUM; €161B total revenues competing with AXA and Zurich Insurance for global property, life, and institutional investment management.
Allianz SE is a Munich, Germany-based global financial services company — listed on the Frankfurt Stock Exchange (ETR: ALV) and one of the world's 30 most valuable brands (Interbrand #29) — operating as one of the world's largest insurance and asset management companies serving 100+ million customers across 70+ countries with property and casualty insurance (home, auto, commercial), life and health insurance, and investment management through its Allianz Global Investors (AllianzGI) and PIMCO subsidiaries. Founded in 1890 and generating approximately €161 billion in total revenues in fiscal year 2024, Allianz manages over €2.3 trillion in third-party assets under management (primarily through PIMCO, the world's largest active fixed income manager with $1.8+ trillion AUM) — making Allianz one of the largest asset managers in the world alongside BlackRock and Vanguard.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.